NCT01059292暂停不适用
Department of Renal Transplantation, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China
Health Science Center of Xi'an Jiaotong University0 个研究点目标入组 93 人开始时间: 2009年10月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 暂停
- 发起方
- 入组人数
- 93
研究概览
简要总结
TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis. The investigators want to know whether TIPE2 is a risk factor for graft loss and gives rise to the immune dysfunction in renal transplant patients.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20 Years 至 60 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •long-term surival(>5year),AR and CR kidney transplant patients and healty Volunteers as control
排除标准
- •without hepatitis , tumor and infections
研究者
相似试验
已完成
不适用
Peptide GAM Immunoadsorption Therapy in Autoimmune Membranous NephropathyAutoimmune Membranous NephropathyNCT03255447Manchester University NHS Foundation Trust12
已完成
2 期
Rapamycin and Regulatory T Cells in Kidney TransplantationKidney TransplantationNCT01014234Fondazione IRCCS Policlinico San Matteo di Pavia56
Unknown
3 期
TOGETHER - Toronto: Trial to Evaluate the Effect of Peginterferon Lambda for the Treatment of COVID-19Sars-CoV2Covid19NCT04967430University Health Network, Toronto763
撤回
2 期
Treg Cells for AGVHD in Non-myeloablative UCB TransplantHematologic MalignanciesNCT02118311Masonic Cancer Center, University of Minnesota
进行中（未招募）
不适用
Highly Suppressive Treg in Delayed and Slow Graft Function After Kidney TransplantationDGFKidney Transplant ComplicationsNCT04414111St. Louis University180